Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.

The Organoid Cell Atlas

Open access

Abstract

To the Editor — Human organoids hold tremendous potential for biomedical applications 1 , 2 , 3 (Fig. 1a,b ). These three-dimensional structures of cultured cells recapitulate important aspects of in vivo organ development and biological function. They provide tractable in vitro models of human physiology and pathology, thereby enabling interventional studies that are difficult or impossible to conduct in human subjects. For example, organoids allow genetic and pharmacological manipulation in a complex cellular context that reflects human biology, and they enable investigations of the early stages of organ development and disease onset. Human organoids complement (and may eventually replace) animal models in many areas of preclinical drug development. Moreover, they provide patient-specific ‘avatars’ for drug development and precision therapies, including treatments for cancer, rare genetic diseases (such as cystic fibrosis) and complex multifactorial disorders (such as epilepsy). Finally, they promise to contribute to regenerative medicine, with the goal of producing functional biological structures that can be transplanted into patients. Fig. 1: Combining organoids and single-cell technology for biomedical discovery and regenerative therapy. a , Organoids can be derived from adult stem cells, which are already committed to a specific cell lineage, tissue and/or organ, or from pluripotent cells, which can give rise to a broad set of cell types but requires more complex differentiation protocols. b , Human organoids are broadly useful for in vitro modeling of biological functions, drug testing and regenerative medicine. c , Key challenges for advancing organoid research include characterization and validation of organoids, development of new organoid protocols, and applications of organoids in basic biology and biomedical research. d , Single-cell technologies promise to advance organoid research by enabling systematic validation of the derived organoids, by informing organoid protocol development, and by providing a high-resolution readout for functional perturbation experiments in human organoids. Full size image

Overview

CoChat Summary

TL;DR

The paper announces the Organoid Cell Atlas, an open collaborative network within the Human Cell Atlas, and its EU H2020-funded HCA|Organoid pilot project. It argues that combining human organoids with single-cell and spatial profiling can improve organoid validation, protocol development, and functional perturbation studies.

Key findings

  • The Organoid Cell Atlas is launched as an HCA Biological Network with four complementary directions: standardize single-cell profiling of human organoids, facilitate access to organoid data via HCA infrastructure, establish computational methods connecting organoid profiles with primary tissue data, and contextualize organoids using HCA profiles of their in vivo counterparts.
  • The EU H2020 HCA|Organoid pilot will generate single-cell transcriptome profiles, epigenome maps, and detailed imaging data in selected human organoids; for colon and brain, it will derive and characterize organoids from 100 whole-genome-sequenced individuals each.
  • The Organoid Cell Atlas Portal will build on the HCA Data Coordination Platform and provide interactive exploration, data-driven selection of organoids for functional experiments, comparison of disease-specific organoids against normal references, and cell–cell alignments between organoid and primary tissue profiles.
  • Disease-centric pilot studies will include CRISPR screening with single-cell transcriptome readout (CROP-seq) and disease modeling of genetic epilepsy using brain organoids selected from the atlas; an initial version is planned within two years.

Methods

  • This is a correspondence/perspective piece, not a primary research study; it describes a planned consortium, data infrastructure, and pilot project rather than reporting completed experiments or results.
  • Planned data generation includes single-cell transcriptome profiles, epigenome maps, and detailed imaging in human organoids, with colon and brain organoids derived from 100 whole-genome-sequenced individuals each; colon organoids come from adult stem cells and brain organoids from pluripotent cells.
  • Planned analyses include standardization and validation of organoid workflows, community metadata standards, computational alignment and comparison of cells between organoids and corresponding primary tissues, and interactive visualization for quality control and exploratory analysis.

Limitations

  • The paper states that current organoid protocols may not faithfully represent the diversity of cell types in primary tissue, including non-parenchymal cells such as immune cells and stroma, and are limited in accounting for environmental exposures and organismal aging; it calls for robust protocols yielding adequate tissue organization, differentiated cells, vascularization, immune cell infiltration, and, for some organs, a microbiome.
  • The paper states that better characterization and validation are needed, including extensive replication to quantify technical and biological variation and inclusion of genetically diverse donors to assess interindividual variation.
  • Evident from the text: this is a proposal and pilot announcement with no empirical results or completed atlas; the initial version is planned within two years, and extensive further work is said to be needed.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41587-020-00762-x

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Combining organoids and single-cell technology for biomedical discovery and regenerative therapy. a, Organoids can be derived from adult stem cells, which are already committed to a specific cell lineage, tissue and/or organ, or from pluripotent cells, which can give rise to a broad set of cell types but requires more complex differentiation protocols. b, Human organoids are broadly useful for in vitro modeling of biological functions, drug testing and regenerative medicine. c, Key challenges for advancing organoid research include characterization and validation of organoids, development of new organoid protocols, and applications of organoids in basic biology and biomedical research. d, Single-cell technologies promise to advance organoid research by enabling systematic validation of the derived organoids, by informing organoid protocol development, and by providing a high-resolution readout for functional perturbation experiments in human organoids.
Fig. 1 Combining organoids and single-cell technology for biomedical discovery and regenerative therapy. a, Organoids can be derived from adult stem cells, which are already committed to a specific cell lineage, tissue and/or organ, or from pluripotent cells, which can give rise to a broad set of cell types but requires more complex differentiation protocols. b, Human organoids are broadly useful for in vitro modeling of biological functions, drug testing and regenerative medicine. c, Key challenges for advancing organoid research include characterization and validation of organoids, development of new organoid protocols, and applications of organoids in basic biology and biomedical research. d, Single-cell technologies promise to advance organoid research by enabling systematic validation of the derived organoids, by informing organoid protocol development, and by providing a high-resolution readout for functional perturbation experiments in human organoids.CC BY · PubMed Central
Fig. 2 Connecting single cells in human organoids and in primary tissue samples via the Organoid Cell Atlas. a, Single-cell profiling of human organoids (left) and of human primary tissue samples (right) provides complementary information. Data integration between single-cell profiles from organoids and primary tissues makes it possible to investigate the same cell type in both contexts, allowing each approach to play to its strengths. b, The Organoid Cell Atlas Portal will implement key features for analyzing and interpreting single-cell data from human organoids in the biological context provided by HCA profiles of their in vivo counterparts.
Fig. 2 Connecting single cells in human organoids and in primary tissue samples via the Organoid Cell Atlas. a, Single-cell profiling of human organoids (left) and of human primary tissue samples (right) provides complementary information. Data integration between single-cell profiles from organoids and primary tissues makes it possible to investigate the same cell type in both contexts, allowing each approach to play to its strengths. b, The Organoid Cell Atlas Portal will implement key features for analyzing and interpreting single-cell data from human organoids in the biological context provided by HCA profiles of their in vivo counterparts.CC BY · PubMed Central

Verification

Claims the paper makes

1 Valid · 0 Not valid · 1 Not checked · 13 Own results and interpretations

5 more claims

Create a free account to see all 15 claims and to verify the 5 references still open.

See all claims — free account
  • It may state two separate claims as one. 2
  • Probably not a substantial claim. 3

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 16 references

Cited by

See all 189

Metadata

Authors
the Human Cell Atlas ‘Biological Network’ Organoids, Bock, C., Boutros, M., Camp, J. G., Clarke, L., Clevers, H., Knoblich, J. A., Liberali, P., Regev, A., Rios, A. C., Stegle, O., Stunnenberg, H. G., Teichmann, S. A., Treutlein, B., & Vries, R. G. J.
Affiliations
  • Broad Institute (US)
  • Austrian Academy of Sciences (AT)
  • German Cancer Research Center (DE)
  • European Bioinformatics Institute (GB)
  • Institute of Molecular Biotechnology (AT)
  • Royal Netherlands Academy of Arts and Sciences (NL)
  • Wellcome Sanger Institute (GB)
  • University of Cambridge (GB)
  • ETH Zurich (CH)
Corresponding author
Bock, Christoph
Venue
Nature Biotechnology
Published
2020-12-31
Volume
39
Issue
1
Pages
13-17
ISSN
  • 0733-222X (ISSN-L)
  • 1087-0156
  • 1546-1696
OpenAlex
W3117494630
Cited by
171
References
16
Citations by year
2026: 25 · 2025: 27 · 2024: 31 · 2023: 31 · 2022: 29 · 2021: 27
FWCI
7.14
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Biotechnology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (publishedVersion, other-oa)
  • DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by)
  • Repository for Publications and Research Data (ETH Zurich) (submittedVersion, cc-by)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • KNAW research portal (Royal Academy of Art and Sciences (KNAW)) (submittedVersion, other-oa)
  • ETH Zürich Research Collection (cc-by)
Funders
  • National Science Foundation
  • Howard Hughes Medical Institute
  • Massachusetts Institute of Technology
  • Novartis Foundation (16B097)
  • Friedrich Miescher Institute for Biomedical Research
  • Deutsches Krebsforschungszentrum
  • Lahore University of Management Sciences
  • Wellcome Trust (104640/Z/14/Z, 104640, 092096)
  • European Molecular Biology Laboratory
  • Broad Institute
  • Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
  • Cancer Research UK (C13474/A18583, 092096)
  • European Commission (874769, 695642, HORIZON2020)
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (135715, 31003A)
  • Koninklijke Nederlandse Akademie van Wetenschappen
  • Österreichischen Akademie der Wissenschaften (SFB F78)
  • Austrian Science Fund (SFB F78, F7803‐B)
  • Eidgenössische Technische Hochschule Zürich (ETH-17 13-2, ETH-10 15–2)
  • Universität Wien
  • Medizinische Universität Wien
  • Bundesministerium für Bildung, Wissenschaft und Forschung
  • Oncode Institute
  • Klarman Cell Observatory, Broad Institute
  • Functional Genomics Center Zurich
  • H2020 European Research Council (693184, 679146)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
Keywords
human organoids, single-cell technologies, pluripotent cell differentiation, adult stem cells, in vitro disease model, drug testing, regenerative medicine, precision medicine
MeSH terms
Atlases as Topic, Humans, Organoids, Databases, Factual, Genome, Computational Biology, Bioengineering, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Organoid Cell Atlas. https://app.cochat.ai/papers/10.1038/s41587-020-00762-x
The paper
the Human Cell Atlas ‘Biological Network’ Organoids, Bock, C., Boutros, M., Camp, J. G., Clarke, L., Clevers, H., Knoblich, J. A., Liberali, P., Regev, A., Rios, A. C., Stegle, O., Stunnenberg, H. G., Teichmann, S. A., Treutlein, B., & Vries, R. G. J. (2021). The Organoid Cell Atlas. Nature Biotechnology. https://doi.org/10.1038/s41587-020-00762-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.